Michael Veness

7.0k total citations · 1 hit paper
133 papers, 4.6k citations indexed

About

Michael Veness is a scholar working on Oncology, Epidemiology and Otorhinolaryngology. According to data from OpenAlex, Michael Veness has authored 133 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Oncology, 65 papers in Epidemiology and 38 papers in Otorhinolaryngology. Recurrent topics in Michael Veness's work include Nonmelanoma Skin Cancer Studies (64 papers), Ear and Head Tumors (44 papers) and Head and Neck Cancer Studies (38 papers). Michael Veness is often cited by papers focused on Nonmelanoma Skin Cancer Studies (64 papers), Ear and Head Tumors (44 papers) and Head and Neck Cancer Studies (38 papers). Michael Veness collaborates with scholars based in Australia, Canada and Singapore. Michael Veness's co-authors include Gary J. Morgan, Carsten E. Palme, Val Gebski, Jonathan R. Clark, Julie R. Howle, Christopher J. O’Brien, Michael Poulsen, Dakshika A. Gunaratne, Célèste Lebbé and Andreas Stang and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Veness

129 papers receiving 4.5k citations

Hit Papers

Merkel cell carcinoma 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Merkel cell carcinoma
    2017 377 citations Michael Veness et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Veness Australia 39 3.2k 2.4k 1.5k 1.0k 911 133 4.6k
C. Wayne Cruse United States 35 3.2k 1.0× 1.8k 0.7× 779 0.5× 237 0.2× 213 0.2× 105 4.3k
David G. Brodland United States 37 2.4k 0.8× 2.7k 1.1× 2.3k 1.5× 313 0.3× 298 0.3× 109 4.6k
Randall K. Roenigk United States 42 1.8k 0.6× 2.0k 0.8× 2.2k 1.4× 499 0.5× 465 0.5× 128 4.5k
John A. Zitelli United States 42 2.3k 0.7× 2.6k 1.1× 1.8k 1.2× 145 0.1× 135 0.1× 123 4.9k
Upendra Parvathaneni United States 25 1.6k 0.5× 278 0.1× 135 0.1× 693 0.7× 626 0.7× 128 2.5k
Dianna Roberts United States 52 3.1k 1.0× 752 0.3× 188 0.1× 254 0.2× 136 0.1× 129 6.9k
Jerry D. Brewer United States 33 1.6k 0.5× 1.1k 0.5× 983 0.7× 303 0.3× 271 0.3× 127 2.9k
Marc D. Brown United States 26 1.1k 0.4× 983 0.4× 1.0k 0.7× 222 0.2× 221 0.2× 70 2.6k
Scott A. McLean United States 29 1.0k 0.3× 242 0.1× 99 0.1× 149 0.1× 133 0.1× 80 2.5k
Scott P. Stringer United States 42 2.1k 0.7× 502 0.2× 227 0.2× 65 0.1× 58 0.1× 136 5.0k

Countries citing papers authored by Michael Veness

Since Specialization
Citations

This map shows the geographic impact of Michael Veness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Veness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Veness more than expected).

Fields of papers citing papers by Michael Veness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Veness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Veness. The network helps show where Michael Veness may publish in the future.

Co-authorship network of co-authors of Michael Veness

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Veness. A scholar is included among the top collaborators of Michael Veness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Veness. Michael Veness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tai, Patricia, et al.. (2025). Merkel Cell Carcinoma of the Skin: Deducing the Pattern of Spread from an International Aggregated Database of 949 Patients. Current Oncology. 32(4). 211–211. 1 indexed citations
2.
Girgis, Christian M., et al.. (2024). Acute Diabetes-Related Complications in Patients Receiving Chemoradiotherapy for Head and Neck Cancer. Current Oncology. 31(2). 828–838. 1 indexed citations
3.
Zhang, Enjie, Mark Knox, Michael Veness, et al.. (2024). Outcomes With Radiation Therapy as Primary Treatment for Unresectable Cutaneous Head and Neck Squamous Cell Carcinoma. Clinical Oncology. 38. 103739–103739. 1 indexed citations
4.
Joseph, Kurian, Michael Veness, Elizabeth Barnes, & Agata Rembielak. (2023). Radiotherapy in Skin Cancer. PubMed. 29(24). 1041–2.
5.
Howle, Julie R., et al.. (2022). Immunotherapy in advanced cutaneous squamous cell carcinoma: Sydney west cancer network experience. ANZ Journal of Surgery. 93(1-2). 235–241. 5 indexed citations
6.
Low, Tsu‐Hui, Ardalan Ebrahimi, Michael Veness, et al.. (2022). Evolution of Head and Neck Cutaneous Squamous Cell Carcinoma Nodal Staging—An Australian Perspective. Cancers. 14(20). 5101–5101. 5 indexed citations
7.
Howle, Julie R., et al.. (2021). Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience. Journal of Medical Imaging and Radiation Oncology. 65(6). 760–767. 5 indexed citations
8.
Goldinger, Simone M., Shaun Chou, Julie R. Howle, et al.. (2021). Merkel cell carcinoma in situ: A systematic review of prognosis and management. Australasian Journal of Dermatology. 63(1). e6–e12. 5 indexed citations
9.
Veness, Michael, E. Cooper, Richard Fox, et al.. (2021). Outcomes of patients with metastatic cutaneous squamous cell carcinoma to the axilla: a multicentre cohort study. ANZ Journal of Surgery. 91(5). 878–884. 4 indexed citations
10.
Satgunaseelan, Laveniya, Rebecca Asher, Tsu‐Hui Low, et al.. (2020). The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: An international multi-institutional analysis. Oral Oncology. 110. 104875–104875. 62 indexed citations
11.
Howle, Julie R., et al.. (2019). Sentinel lymph node biopsy in clinically node‐negative Merkel cell carcinoma: the Westmead Hospital experience. ANZ Journal of Surgery. 89(5). 520–523. 9 indexed citations
12.
Garbutcheon‐Singh, K. Benjamin & Michael Veness. (2019). The role of radiotherapy in the management of non‐melanoma skin cancer. Australasian Journal of Dermatology. 60(4). 265–272. 31 indexed citations
13.
Ebrahimi, Ardalan, Peter P. Luk, Tsu‐Hui Low, et al.. (2019). Positive survival trend in metastatic head and neck cutaneous squamous cell carcinoma over four‐decades: Multicenter study. Head & Neck. 41(11). 3826–3832. 6 indexed citations
14.
Gunaratne, Dakshika A., et al.. (2018). Systematic review of sentinel lymph node biopsy in Merkel cell carcinoma of the head and neck. Head & Neck. 40(12). 2704–2713. 21 indexed citations
15.
Gunaratne, Dakshika A. & Michael Veness. (2018). Efficacy of hypofractionated radiotherapy in patients with non‐melanoma skin cancer: Results of a systematic review. Journal of Medical Imaging and Radiation Oncology. 62(3). 401–411. 28 indexed citations
16.
Gupta, Ruta, Joel Smith, Bruce Ashford, et al.. (2017). Metastases to the parotid gland - A review of the clinicopathological evolution, molecular mechanisms and management. Surgical Oncology. 27(1). 44–53. 8 indexed citations
17.
Veness, Michael & Julie R. Howle. (2011). Merkel cell carcinoma metastatic to the transverse colon: Disease free after six years - cure or just prolonged remission?. Australasian Journal of Dermatology. 52(4). 295–297. 3 indexed citations
18.
Morgan, Gary J., et al.. (2009). Metastatic cutaneous squamous cell carcinoma of the head and neck. Cancer. 115(9). 1883–1891. 101 indexed citations
19.
Palme, Carsten E., et al.. (2007). The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck. Current Opinion in Otolaryngology & Head & Neck Surgery. 15(2). 103–106. 18 indexed citations
20.
Veness, Michael, et al.. (2002). Basal cell carcinoma of the lip treated with radiotherapy. Australasian Journal of Dermatology. 43(1). 15–19. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Wayne Cruse Breakdown of academic impact, for papers by David G. Brodland Breakdown of academic impact, for papers by Randall K. Roenigk Breakdown of academic impact, for papers by John A. Zitelli Breakdown of academic impact, for papers by Upendra Parvathaneni Breakdown of academic impact, for papers by Dianna Roberts Breakdown of academic impact, for papers by Jerry D. Brewer Breakdown of academic impact, for papers by Marc D. Brown Breakdown of academic impact, for papers by Scott A. McLean Breakdown of academic impact, for papers by Scott P. Stringer
Rankless by CCL
2026